Use of an IL-6 inhibitor has the potential to prevent the cytokine storm caused by severe COVID-19 infection.
Katie E. Barber, PharmD*
Advertisement
Articles by Katie E. Barber, PharmD*
A commentary on β-lactam combination therapy for methicillin-resistant Staphylococcus aureus bacteremia.
Advertisement
Latest Updated Articles
- Are Two Antibiotics Better Than One?
April 5th 2019
- Using IL-6 Inhibitors to Treat COVID-19
August 17th 2020
Advertisement
Advertisement
Trending on Contagion Live
1
FDA Approves Ensitrelvir as First Oral Postexposure Prevention Option for COVID-19
2
Aging With HIV: Managing Comorbidities in a Population That Has Outlived Its Prognosis
3
Migration Trends Demonstrate Rare, But Increasing Malaria Cases in New York City
4
Comparable Safety and No Emergent Resistance With Ceftobiprole vs Daptomycin in S aureus Bacteremia
5